In this study, the loss of PERK induced paraptosis of melanoma cells, releasing tumor Ags that then promoted type I IFN production in tumor-associated dendritic cells (DCs), resulting in increased antitumor immunity (59). The gene discussed is EIF2AK3; the disease is melanoma.